Back to Journals » Cancer Management and Research » Volume 14

Combined Lorlatinib, Dabrafenib, and Trametinib Treatment for ROS1-Rearranged Advanced Non-Small-Cell Lung Cancer with a Lorlatinib-Induced BRAF V600E Mutation: A Case Report

Total article views   HTML views PDF downloads Totals
3,191 Dovepress* 2,924+ 83 3,007
PubMed Central* 267 121 388
Totals 3,191 204 3,395
*Since 15 November 2022
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 1 1

View citations on PubMed Central and Google Scholar